Cortellis
By Bioinfogate
Cortellis is a comprehensive life sciences intelligence platform designed for pharmaceutical companies, biotech firms, and regulatory professionals.
Publisher review
Cortellis is a comprehensive life sciences intelligence platform designed for pharmaceutical companies, biotech firms, and regulatory professionals. Originally launched by Thomson Reuters in 2012 and now operated by Clarivate, it integrates billions of curated data points across drug discovery, development, regulatory compliance, and commercial intelligence. The platform serves scientists, regulatory teams, and business strategists with modular solutions spanning Competitive Intelligence, Deals Intelligence, Clinical Trials Intelligence, and more.
Cortellis is particularly valuable for teams needing to track 580,000+ drugs and biologics, 44,000+ genes and targets, or monitor 325,000+ clinical trials across 80+ regulatory jurisdictions. Its AI-enabled Regulatory Assistant, launched in December 2025, provides multilingual document summarization and comparison capabilities specifically for compliance professionals. The platform's depth comes from consolidating 1.2 million patents, 540,000 bioactive compounds, and 1.7 million molecular interactions into a unified system.
Cortellis stands out for its scientific design approach - features like target validation tools and experimental model tracking (138,000+ models) were built by scientists for research workflows. The platform maintains 100% analyst-checked data quality across its 2.4 million+ pharmacology data points, though this rigor contributes to implementation timelines. While Cortellis leads in coverage breadth versus specialists like Citeline (focused on trials) or AlphaSense (document search), its enterprise pricing reflects the comprehensive data access.
The platform's December 2025 AI update introduced agentic AI for regulatory queries but currently limits AI features to report updates rather than real-time data analysis. Competitors like DealForma emphasize faster implementation for deal tracking, but Cortellis retains dominance in therapeutic area depth and historical data spanning 30+ years of pharmaceutical intelligence.
How it works
-
Regulatory AI Assistant
Agentic AI tool launched December 2025 providing multilingual document summarization, guidance comparisons, and cited answers for compliance teams.
-
Drug Discovery Intelligence
Integrates 540,000 bioactive compounds and 1.7 million molecular interactions from MetaCore for target identification.
-
Clinical Trials Coverage
Tracks 325,000+ clinical trials worldwide with 2.4 million pharmacology data points across therapeutic areas.
-
Deals Intelligence
Monitors 90,000+ pharmaceutical transactions with detailed filters for partnership analysis and benchmarking.
-
Safety Intelligence
Off-X module aggregates adverse event reports and safety signals from global regulatory sources.
-
Target Validation
Supports identification of 44,000+ genes and targets with 138,000 experimental models for research.
-
Regulatory Jurisdictions
Covers requirements across 80+ countries including FDA, EMA, and emerging market agencies.
Strengths and trade-offs
Strengths
- Maintains 100% analyst-verified data quality across 2.4 million+ pharmacology data points and 325,000 clinical trials.
- The December 2025 AI update introduced agentic capabilities for regulatory document comparison, reducing manual review time by 70% per user reports.
- Offers unmatched therapeutic area depth with 580,000+ tracked drugs and 44,000+ genes/targets for discovery research.
- Integrates 30+ years of historical intelligence including 1.2 million patents and 90,000+ deal records for trend analysis.
Trade-offs
- Enterprise contracts require 12-18 month implementation timelines due to data validation processes.
- AI features are currently limited to pre-generated report updates rather than real-time data analysis.
- Proprietary data structures require significant training compared to simpler platforms like Zymewire.
- High annual costs (typically $50k+) place it out of reach for smaller biotechs without enterprise budgets.
Pricing context
Custom enterprise pricing only, typically $50k+ annually with multi-year contracts common.
Getting started with Cortellis
-
Request demo
Contact Clarivate sales to schedule a Cortellis platform demo and discuss enterprise licensing options tailored to your organization's needs.
-
Complete implementation
Work with Clarivate consultants during the 12-18 month implementation period to validate data requirements and configure therapeutic area modules.
-
Train teams
Schedule training sessions for scientists and analysts on platform navigation, target validation tools, and regulatory AI assistant features.
-
Load research parameters
Input your drug targets, therapeutic areas, or competitor pipelines to generate customized intelligence reports and clinical trial alerts.
-
Deploy AI assistant
Activate the Regulatory AI Assistant for document summarization tasks and configure alerts for compliance updates across selected jurisdictions.
Frequently Asked Questions
What is Cortellis used for?
Cortellis is a life sciences intelligence platform for pharmaceutical companies, biotech firms, and regulatory professionals. It integrates billions of curated data points across drug discovery, development, regulatory compliance, and commercial intelligence, serving scientists, regulatory teams, and business strategists.
What are the key features of Cortellis?
Cortellis offers features like Regulatory AI Assistant, Drug Discovery Intelligence, Clinical Trials Coverage, Deals Intelligence, Safety Intelligence, Target Validation, and Regulatory Jurisdictions. These tools support tasks from target identification to monitoring clinical trials and regulatory compliance across 80+ countries.
How does Cortellis AI Regulatory Assistant work?
Launched in December 2025, Cortellis AI Regulatory Assistant provides multilingual document summarization, guidance comparisons, and cited answers for compliance teams. It uses agentic AI to reduce manual review time by 70%, though it currently focuses on pre-generated report updates rather than real-time analysis.
What is Cortellis pricing like?
Cortellis offers custom enterprise pricing, typically starting at $50k annually with multi-year contracts common. Its comprehensive data access and implementation timelines of 12-18 months reflect its enterprise focus, making it less accessible for smaller biotechs without significant budgets.
What are the strengths of Cortellis?
Cortellis maintains 100% analyst-verified data quality across 2.4 million+ pharmacology data points and 325,000 clinical trials. It offers unmatched therapeutic area depth, integrates 30+ years of historical intelligence, and features AI capabilities that significantly reduce manual regulatory review time.
How does Cortellis compare to alternatives?
Cortellis leads in coverage breadth versus specialists like Citeline (trials) or AlphaSense (document search). While competitors like DealForma offer faster implementation, Cortellis excels in therapeutic area depth and historical data spanning 30+ years, though its enterprise pricing and training requirements are higher.
Alternatives
- Citeline ↗
- AlphaSense ↗
- DealForma ↗
How Cortellis compares
Direct head-to-head against 3 competitors. Picked by 7wData.
Cortellis
- Pricing
- Custom enterprise pricing only, typically $50k+ annually with multi-year contracts common.
- Target
- Cortellis is a comprehensive life sciences intelligence platform designed for pharmaceutical companies, biotech firms, and regulatory professionals.
- Strength
- Maintains 100% analyst-verified data quality across 2.4 million+ pharmacology data points and 325,000 clinical trials.
- Watch for
- Enterprise contracts require 12-18 month implementation timelines due to data validation processes.
Citeline
- Pricing
- Six figures annually (enterprise)
- Target
- R&D & clinical ops needing pipeline data
- Deployment
- Enterprise onboarding (weeks)
- Strength
- Proprietary TrialTrove database with 60,000+ sources
- Watch for
- High annual contract costs
AlphaSense
- Pricing
- $10K–$100K+/year per team
- Target
- CI teams needing document research
- Deployment
- Days to weeks with training
- Strength
- Generative search with cited answers
- Watch for
- Focuses more on unstructured qualitative data
DealForma
- Pricing
- Custom pricing
- Target
- Biopharma business development teams
- Deployment
- Quick setup
- Strength
- Comprehensive coverage of biopharmaceutical transactions
- Watch for
- Limited to deal monitoring and analytics
User reviews
No user reviews yet. Be the first to write one.
Sources
Reporting on this tool draws on these publicly available sources.